4
Changes in Ownership
KIORA PHARMACEUTICALS INC Filed Acc 0001144204-19-005042
Options or other derivatives
- Chief Medical Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wirostko Barbara · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-02-01 | Grant or award : show line 1 in the form Stock Option (right to buy) | +50,000 | $0.48 | 2029-02-01 | 50,000 | 50,000 | D |
Loading xslF345X03/tv512442_form4.xml…